Search
-
Latinos lean Democratic on climate change, safety as midterms draw closer
New Axios/Ipsos poll finds views more split on immigration among this audience
-
Changing norms around free speech?
What are the limits of free speech? Are the boundaries shifting? And, if so, will these shifts be just normative? Or will they be institutional? We take a stab at understanding these ideas in five data points.
-
Here’s what inflation is changing (and what it isn’t)
In less than five minutes of reading time, we’ll give you all the data and context you need to get you up to speed on Ipsos’ latest wave of the Coronavirus Consumer Tracker.
-
[WEBINAR] ‘Healthy’ Positioning That Changes Behavior
Positioning is the single most important strategic decision for brand leaders – informing all subsequent marketing, communication, and brand experience strategies. Thus, it’s imperative to get it right.
-
SHOPTALK Fall Meetup
Shoptalk Fall Meetup is a one-of-a-kind, online meetings and collaboration event that brings a large group within the retail industry together for double opt-in meetings and small group discussions.
-
Back-to-school shopping off to a slow start
Our latest Thought Starter provides details on what Americans expect to spend on back-to-school items.
-
New at Ipsos: The latest research, data and reports
Here's how to find Ipsos' latest polling and insights.
-
Biosimilar Launch Strategy Development
A very effective approach to dealing with inherent uncertainty is scenario-based competitive gaming, especially when it is powered by dedicated supporting research. Here’s why.
-
Ipsos Core Political : Presidential Approval Tracker (08/03/2022)
This week’s Ipsos Core Political has President Biden with a 38% approval rating, and 69% of Americans say things in this country are off on the wrong track. The economy remains the nation’s most important problem and the issue Americans want Biden to prioritize.
-
A new era in multiple sclerosis
Referencing Ipsos’ syndicated MS Therapy Monitor data, we explore the impact of the anti-CD20s since their availability – specifically, where they are being used, how they are being used, and neurologists’ perceptions of them.